Although yesterday’s announcement of a Pharmac funding boost is a significant and positive step for medicines access in New Zealand, uncertainty and concern remain for many melanoma patients in New Zealand.
MyLifeMatters is a collective of patient advocate organisations representing more than 1 million patients with cancers, rare disorders, diabetes, and other life limiting conditions calling for the New Zealand Government to start investing in new and breakthrough medicines at the same level as other OECD countries.
Melanoma New Zealand is welcoming National’s policy announcement to fund 13 essential cancer medicines, saying it is a much-needed lifeline and will improve patient outcomes for thousands of New Zealanders.